文献速递衰弱、肌少症与跌倒老年慢病共病管理老年综合评估

高龄疑似心梗患者解读高敏肌钙蛋白需考虑衰弱与共病

Accounting for frailty and multimorbidity when interpreting high-sensitivity troponin I tests in oldest old.
PubMed 文献 · J Am Geriatr Soc · 2021-11-18

本研究纳入268例≥75岁疑似心梗的急诊后老年患者,发现71%存在高敏肌钙蛋白I升高但仅4.5%确诊心梗。hs-TnI与心梗相关(AUROC 0.751),最佳切点141 ng/L;≥141 ng/L与临床衰弱量表相关,<141 ng/L与CIRS心脏亚评分相关;衰弱而非hs-TnI预测3个月死亡。

要点

  • 高龄疑似心梗者hs-TnI升高常见但心梗确诊率低,解读需谨慎。
  • hs-TnI≥141 ng/L时需关注衰弱,<141 ng/L时需关注心血管共病。
  • 衰弱(CFS)而非hs-TnI水平预测3个月死亡。

核心结论

  • 在疑似心梗的老年患者中,解读急诊hs-TnI时应仔细考虑衰弱和心血管共病。

研究设计与样本

  • 纵向研究,纳入≥75岁疑似心梗患者268例(女性147例,中位年龄85岁,IQR 80-89),急诊就诊后收入急性老年病房。
  • 采用累积疾病评定量表(CIRS)评估共病,临床衰弱量表(CFS)评估衰弱。

主要发现

  • hs-TnI升高191例(71%,中位23 ng/L,IQR 11-65),但心梗仅12例(4.5%)。
  • hs-TnI与心梗显著相关(AUROC 0.751,95%CI 0.580-0.922,p=0.003),最佳切点141 ng/L。
  • hs-TnI≥141 ng/L与CFS显著相关(OR 1.58,95%CI 1.15-2.18,p=0.005)。
  • hs-TnI<141 ng/L与CIRS心脏亚评分相关(OR 1.36,95%CI 1.07-1.71,p=0.011)。
  • CFS而非hs-TnI水平预测3个月死亡率。

关键数值与推荐

  • hs-TnI诊断心梗的AUROC为0.751(95%CI 0.580-0.922,p=0.003),最佳切点141 ng/L。
  • hs-TnI≥141 ng/L与CFS的OR为1.58(95%CI 1.15-2.18,p=0.005)。
  • hs-TnI<141 ng/L与CIRS心脏亚评分的OR为1.36(95%CI 1.07-1.71,p=0.011)。

临床怎么用

  • 对≥75岁疑似心梗患者,hs-TnI升高不应直接等同于心梗,需结合衰弱和共病评估。
  • hs-TnI≥141 ng/L时提示衰弱可能,应进行综合评估。
  • hs-TnI<141 ng/L但存在心血管共病时,仍需关注共病管理。
  • 3个月死亡风险预测应重视衰弱评估而非仅依赖hs-TnI水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older patients evaluated in Emergency Departments (ED) for suspect Myocardial Infarction (MI) frequently exhibit unspecific elevations of serum high-sensitivity troponin I (hs-TnI), making interpretation particularly challenging for emergency physicians. The aim of this longitudinal study was to identify the interaction of multimorbidity and frailty with hs-TnI levels in older patients seeking emergency care. METHODS: A group of patients aged≥75 with suspected MI was enrolled in our acute geriatric ward immediately after ED visit. Multimorbidity and frailty were measured with Cumulative Illness Rating Scale (CIRS) and Clinical Frailty Scale (CFS), respectively. The association of hs-TnI with MI (main endpoint) was assessed by calculation of the Area Under the Receiver-Operating Characteristic Curve (AUROC), deriving population-specific cut-offs with Youden test. The factors associated with hs-TnI categories, including MI, CFS and CIRS, were determined with stepwise multinomial logistic regression. The association of hs-TnI with 3-month mortality (secondary endpoint) was also investigated with stepwise logistic regression. RESULTS: Among 268 participants (147 F, median age 85, IQR 80-89), hs-TnI elevation was found in 191 cases (71%, median 23 ng/L, IQR 11-65), but MI was present in only 12 cases (4.5%). hs-TnI was significantly associated with MI (AUROC 0.751, 95% CI 0.580-0.922, p = 0.003), with an optimal cut-off of 141 ng/L. hs-TnI levels ≥141 ng/L were significantly associated with CFS (OR 1.58, 95% CI 1.15-2.18, p = 0.005), while levels <141 ng/L were associated with the cardiac subscore of CIRS (OR 1.36, 95% CI 1.07-1.71, p = 0.011). CFS, but not hs-TnI levels, predicted 3-month mortality. CONCLUSIONS: In geriatric patients with suspected MI, frailty and cardiovascular multimorbidity should be carefully considered when interpreting emergency hs-TnI testing.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Ticinesi A, Nouvenne A, Cerundolo N, et al. Accounting for frailty and multimorbidity when interpreting high-sensitivity troponin I tests in oldest old. J Am Geriatr Soc. 2021. PMID: 34792185. doi:10.1111/jgs.17566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。